Production- and Purification-Relevant Properties of Human and Murine Cytomegalovirus

• Published in: Viruses Vol. 13; no. 12; p. 2481
• Main Authors: Ravlić, Sanda, Brgles, Marija, Hiršl, Lea, Jonjić, Stipan, Halassy, Beata
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 10-12-2021; MDPI
• Subjects: Animals; Anion-exchange chromatography; Cell culture; Cell Line; Chromatography; Chromatography, Ion Exchange; Congenital defects; Cryopreservation; Cytomegalovirus; Cytomegalovirus - growth & development; Cytomegalovirus - isolation & purification; Deoxyribonucleic acid; DNA; Enzyme-linked immunosorbent assay; Exosomes; Gene therapy; Genomes; HCMV; Humans; Immunocompromised hosts; Immunosurveillance; Infections; Ion-exchange chromatography; MCMV; Mice; Muromegalovirus - growth & development; Muromegalovirus - isolation & purification; Nanoparticles; Proteins; purification; Storage conditions; Ultracentrifugation; Vaccination; Vaccines; virus; Virus Cultivation; Viruses; Germany; ion exchange chromatography; cytomegalovirus; HCMV; purification; ultracentrifugation; clarification; MCMV; virus
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v13122481

There is a large unmet need for a prophylactic vaccine against human cytomegalovirus (HCMV) to combat the ubiquitous infection that is ongoing with this pathogen. A vaccination against HCMV could protect immunocompromised patients and prevent birth defects caused by congenital HCMV infections. Moreover, cytomegalovirus (CMV) has a number of features that make it a very interesting vector platform for gene therapy. In both cases, preparation of a highly purified virus is a prerequisite for safe and effective application. Murine CMV (MCMV) is by far the most studied model for HCMV infections with regard to the principles that govern the immune surveillance of CMVs. Knowledge transfer from MCMV and mice to HCMV and humans could be facilitated by better understanding and characterization of the biological and biophysical properties of both viruses. We carried out a detailed investigation of HCMV and MCMV growth kinetics as well as stability under the influence of clarification and different storage conditions. Further, we investigated the possibilities to concentrate and purify both viruses by ultracentrifugation and ion-exchange chromatography. Defective enveloped particles were not separately analyzed; however, the behavior of exosomes was examined during all experiments. The effectiveness of procedures was monitored using CCID
assay, Nanoparticle tracking analysis, ELISA for host cell proteins, and quantitative PCR for host cell DNA. MCMV generally proved to be more robust in handling. Despite its greater sensitivity, HCMV was efficiently (100% recovery) purified and concentrated by anion-exchange chromatography using QA monolithic support. The majority of the host genomic DNA as well as most of the host cell proteins were removed by this procedure.